TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 15, No. 19 October 1, 2009
(The next issue will be on October 15, 2009)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
In response to our previous request for feedback, Prof. Leon Poller made the interesting suggestion that brief reviews of important published reports in the area of TF, FVII or TFPI biology would be nice to see. Perhaps even just some quick comments about interesting recent papers in this area would be useful. The trick, of course, is to find the time to do this! So, if anyone would like, at any time, to submit such a brief review, highlight, or even just a quick comment about a paper or papers recently been published in this area, we would be happy to include your comments/contributions in TRIGGER.
-Jim Morrissey
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The 5th International Conference on Thrombosis and Hemostasis: Issues in Cancer will take place in Stresa, Italy, on April 23-25, 2010. Deadline for abstract submission is December 1, 2009. For more information, go to: http://www.icthic.com/
__________________________________________________________
POSITIONS SOUGHT/AVAILABLE
The University of Texas Health Science Center at Tyler invites applications from outstanding scientists for state-funded faculty positions at all levels. Tyler is located midway between Dallas and Shreveport amidst the picturesque lakes and piney woods of East Texas. The mission of the basic and clinical research at the UT Health Science Center focuses on lung injury/repair, pulmonary infectious diseases, cardiovascular diseases, immunology and thoracic oncology, but applicants in other broadly-related fields are welcome. A complete listing and description of current faculty research interests can be found online via UTHSCT's website: http://www.uthct.edu/Research. The successful candidate will bring or establish a dynamic independent research program in a discipline related to the mission of UTHSCT. A strong track record of extramural funding and collaboration is required at the Associate and Full Professor levels and is recommended at the Assistant Professor level. Teaching requirements are minimal. Applicants should submit their curriculum vitae, a statement of future research plans and the names of three references to: Dr. Pierre F. Neuenschwander, Faculty Search Committee Chair, University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, Texas 75708-3154, or by email. (pierre DOT neuenschwander AT uthct DOT edu). Please use the subject line: Faculty Applicant.
UTHSCT is an EEO/AA Employer M/F/V/D. This position is security sensitive and subject to Texas Education Code 51.215 which authorizes the employer to obtain criminal history information.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1j9AYf8_l-cI6qfkNrFPTGD/
Atac FB, Ince DA, Verdi H, Gokmen Z, Yazici AC, Gulcan H, Tarcan A, Taneri A, Sezgin E, and Ozbek N (2009) Lack of association between FXIII-Val34Leu, FVII-323 del/ins, and transforming growth factor
beta1 (915G/T) gene polymorphisms and bronchopulmonary dysplasia (A Single-Center study). DNA Cell Biol
http://www.ncbi.nlm.nih.gov/pubmed/19778283
Barillari G, Frigo MG, Casarotto M, Farnia A, Masse B, Wetzl R, Bianchin A, Rabi A, Malacarne P, Pasca S, and Bigotto E (2009) Use of recombinant activated factor VII in severe post-partum haemorrhage:
Data from the Italian Registry A multicentric observational retrospective study. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/19783283
Bidet A, Boiteux-Vergnes C, and Mouton C (2009) [Acquired and repeated factor VII deficiency during infections outbreaks: Case-report.]. Ann Biol Clin (Paris) 67:587-589.
http://www.ncbi.nlm.nih.gov/pubmed/19789134
Chrusciel P, Goch A, Banach M, Mikhailidis DP, Rysz J, and Goch JH (2009) Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit 15:RA203-RA208
http://www.ncbi.nlm.nih.gov/pubmed/19789523
Clemens N, Frauenknecht K, Katzav A, Sommer C, and von Landenberg P (2009) In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes. Ann N Y Acad Sci 1173:805-813.
http://www.ncbi.nlm.nih.gov/pubmed/19758232
De Rosa S, Cirillo P, Paglia A, Sasso L, Di Palma V, and Chiariello M (2010) Reactive oxygen species and antioxidants in the pathophysiology of cardiovascular disease: Does the actual knowledge justify a clinical approach? Curr Vasc Pharmacol
http://www.ncbi.nlm.nih.gov/pubmed/19758111
Jajoria P, Murthy V, Papalardo E, Romay-Penabad Z, Gleason C, and Pierangeli SS (2009) Statins for the treatment of antiphospholipid syndrome? Ann N Y Acad Sci 1173:736-745.
http://www.ncbi.nlm.nih.gov/pubmed/19758223
John R, Panch S, Hrabe J, Wei P, Solovey A, Joyce L, and Hebbel R (2009) Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg 88:1171-1179.
http://www.ncbi.nlm.nih.gov/pubmed/19766802
Karatela RA and Sainani GS (2009) Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease. Atherosclerosis
http://www.ncbi.nlm.nih.gov/pubmed/19781705
Kubota T, Fukuya Y, Hashimoto R, Kanda T, Suzuki H, Okamura Y, Nanki T, Miyasaka N, and Umezawa K (2009) Possible involvement of chemokine-induced platelet activation in thrombophilic diathesis of antiphospholipid syndrome. Ann N Y Acad Sci 1173:137-145.
http://www.ncbi.nlm.nih.gov/pubmed/19758142
Lee JH, Lee HJ, Bin JH, Hahn SH, Kim SY, Kim HH, and Lee WB (2009) A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a newborn baby. Blood Coagul Fibrinolysis 20:161-164.
http://www.ncbi.nlm.nih.gov/pubmed/19786945
Mota L, Shetty S, Idicula-Thomas S, and Ghosh K (2009) Phenotypic and genotypic characterization of Factor VII deficiency patients from Western India. Clin Chim Acta
http://www.ncbi.nlm.nih.gov/pubmed/19751712
Piotrowski A, Dabrowska-Wojciak I, Mikinka M, Fendler W, Walas W, Sobala W, and Kuczkowski KM (2009) Coagulation abnormalities and severe intraventricular hemorrhage in extremely low birth weight infants. J Matern Fetal Neonatal Med 1-6.
http://www.ncbi.nlm.nih.gov/pubmed/19757338
Poovassery JS, Sarr D, Smith G, Nagy T, and Moore JM (2009) Malaria-induced murine pregnancy failure: Distinct roles for IFN-{gamma} and TNF. J Immunol
http://www.ncbi.nlm.nih.gov/pubmed/19783682
Stahl AL, Sartz L, Nelsson A, Bekassy ZD, and Karpman D (2009) Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS ONE 4:e6990
http://www.ncbi.nlm.nih.gov/pubmed/19750223
Tang Z, Geng G, Huang Q, Xu G, Hu H, Chen J, and Li J (2009) Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis. Med Oncol
http://www.ncbi.nlm.nih.gov/pubmed/19763915
Vestergaard S, Nedergaard H, Jonasdottir O, Wagner KM, Mette NA, and Bjerre J (2009) Effect of X-ray radiation exposure on lyophilized recombinant activated factor VII (formulated for storage at room temperature). Curr Med Res Opin
http://www.ncbi.nlm.nih.gov/pubmed/19775196
______________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
